Todorova Albena, Todorov Tihomir, Georgieva Bilyana, Lukova Michaela, Guergueltcheva Velina, Kremensky Ivo, Mitev Vanyo
Department of Chemistry and Biochemistry, Medical Faculty, Sofia Medical University, 2 Zdrave str., Sofia 1431, Bulgaria.
Neuromuscul Disord. 2008 Aug;18(8):667-70. doi: 10.1016/j.nmd.2008.06.369. Epub 2008 Jul 23.
Duchenne/Becker muscular dystrophy (DMD/BMD), the most common X-linked muscular dystrophy is caused by mutations in the enormously large DMD gene, encoding the protein called dystrophin. This gene was screened in a group of 27 unrelated Bulgarian DMD/BMD patients by MLPA analysis/complete sequencing. We managed to clarify the disease-causing mutation in 96.3% of the analyzed families. The MLPA analysis revealed 17 deletions (including a deletion of the very last exon 79), 6 duplications and 1 point mutation. Two additional point mutations (one of them novel) were detected after complete sequencing of the DMD gene. Altogether, 25 carriers and 11 noncarriers were detected in our families. The MLPA test proved to be a powerful tool in detecting deletions/duplications and in some cases point mutations/polymorphisms along the DMD gene. Using this approach in combination with a direct gene sequencing a number of Bulgarian DMD/BMD patients are genetically clarified and prepared for gene therapy in future.
杜兴氏/贝克氏肌营养不良症(DMD/BMD)是最常见的X连锁肌营养不良症,由巨大的DMD基因突变引起,该基因编码一种名为抗肌萎缩蛋白的蛋白质。通过多重连接探针扩增(MLPA)分析/全序列测序,对一组27名无亲缘关系的保加利亚DMD/BMD患者的该基因进行了筛查。我们成功地在96.3%的分析家庭中明确了致病突变。MLPA分析揭示了17个缺失(包括最后一个外显子79的缺失)、6个重复和1个点突变。在对DMD基因进行全序列测序后,又检测到另外两个点突变(其中一个是新发现的)。在我们的家庭中总共检测到25名携带者和11名非携带者。MLPA检测被证明是检测DMD基因缺失/重复以及在某些情况下检测点突变/多态性的有力工具。通过将这种方法与直接基因测序相结合,许多保加利亚DMD/BMD患者在基因层面得到了明确诊断,并为未来的基因治疗做好了准备。